Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J B D Palmer"'
Publikováno v:
BMJ. 306:1034-1037
OBJECTIVE--To compare safety of salmeterol and salbutamol in treating asthma. DESIGN--Double blind, randomised clinical trial in parallel groups over 16 weeks. SETTING--General practices throughout the United Kingdom. SUBJECTS--25,180 patients with a
Publikováno v:
Thorax. 48:148-153
BACKGROUND: Salmeterol is a potent selective beta 2 agonist that has been shown to have a duration of action in excess of 12 hours. In this study salmeterol and salbutamol were compared over a three month period with a further extension of nine month
Publikováno v:
European Journal of Clinical Pharmacology. 39:281-285
The purpose of the present study was to compare the efficacy and systemic effects of 4 mg and 8 mg doses of salbutamol controlled release (SCR) after single dosing and at steady state in patients with asthma. Fifteen asthmatic patients (Age 36 y, FEV
Autor:
E.H. Walters, S C Stenton, J. B. D. Palmer, M Duddridge, A. Harris, Chris Ward, David J. Hendrick
Publikováno v:
Clinical Experimental Allergy. 20:311-317
Summary We investigated acute bronchoconstriction and changes in airway responsiveness to methacholine following the inhalation of platelet activating factor (PAF) in an open study of 12 non-asthmatic subjects. Ventilatory function was monitored usin
Publikováno v:
The American journal of gastroenterology. 94(7)
OBJECTIVE: Published studies have estimated the rate of Helicobacter pylori (H. pylori) infection in patients with duodenal ulcer disease to be as high as 95%; the majority of remaining duodenal ulcers have been attributed to the use of ulcerogenic d
Publikováno v:
Pulmonary pharmacology. 5(3)
Airway responsiveness to methacholine was measured in nine subjects (22-53 years, seven male) with chronic stable asthma. All subjects were taking inhaled beclomethasone (less than 1000 micrograms daily). The mean baseline FEV1 was 2.841 (77% of pred
Autor:
J. B. D. Palmer, Reijo Salonen
Publikováno v:
The Lancet. 355:2250-2251
Publikováno v:
Lancet (London, England). 336(8727)
The effects of the long-acting beta 2-agonist salmeterol on early and late phase airways events provoked by inhaled allergen were assessed in a group of atopic asthmatic patients. In a placebo-controlled study, salmeterol 50 micrograms inhaled before
Publikováno v:
BMJ. 312:183-183
EDITOR,—Rebecca L Aspinall and Neville W Goodman conclude that patients who participated in placebo controlled studies investigating the role of ondansetron in the management of postoperative nausea and vomiting were denied access to effective trea